The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer

M. Marín-Aguilera, Ò. Reig, M. Milà-Guasch, A. Font, M. Domènech, A. Rodríguez-Vida, J. Carles, C. Suárez, A.G. del Alba, N. Jiménez, I. Victoria, N. Sala-González, M.J. Ribal, S. López, O. Etxaniz, G. Anguera, P. Maroto, P.L. Fernández, A. Prat, B. Mellado

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)
Original languageUndefined/Unknown
JournalInternational Journal of Cancer
DOIs
Publication statusPublished - 2019

Cite this

Marín-Aguilera, M., Reig, Ò., Milà-Guasch, M., Font, A., Domènech, M., Rodríguez-Vida, A., Carles, J., Suárez, C., del Alba, A. G., Jiménez, N., Victoria, I., Sala-González, N., Ribal, M. J., López, S., Etxaniz, O., Anguera, G., Maroto, P., Fernández, P. L., Prat, A., & Mellado, B. (2019). The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.32238